melatonin has been researched along with Central Nervous System Neoplasms in 1 studies
Central Nervous System Neoplasms: Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.
Excerpt | Relevance | Reference |
---|---|---|
" In spite of its unfavorable biopharmaceutic properties, melatonin (MLT) has demonstrated anticancer effects against glioblastoma." | 7.91 | Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of Glioblastoma. ( da Silva, ACG; de Oliveira Junior, ER; Lima, EM; Nascimento, TL; Salomão, MA; Valadares, MC, 2019) |
" In spite of its unfavorable biopharmaceutic properties, melatonin (MLT) has demonstrated anticancer effects against glioblastoma." | 3.91 | Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of Glioblastoma. ( da Silva, ACG; de Oliveira Junior, ER; Lima, EM; Nascimento, TL; Salomão, MA; Valadares, MC, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Oliveira Junior, ER | 1 |
Nascimento, TL | 1 |
Salomão, MA | 1 |
da Silva, ACG | 1 |
Valadares, MC | 1 |
Lima, EM | 1 |
1 other study available for melatonin and Central Nervous System Neoplasms
Article | Year |
---|---|
Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of Glioblastoma.
Topics: Administration, Intranasal; Administration, Oral; Animals; Antineoplastic Agents; Brain; Cell Line, | 2019 |